Edition:
India

Profile: IPCA Laboratories Ltd (IPCA.BO)

IPCA.BO on Bombay Stock Exchange

435.95INR
27 May 2016
Change (% chg)

Rs-5.30 (-1.20%)
Prev Close
Rs441.25
Open
Rs444.70
Day's High
Rs446.90
Day's Low
Rs432.95
Volume
30,281
Avg. Vol
72,140
52-wk High
Rs888.00
52-wk Low
Rs432.95

Ipca Laboratories Ltd. is an India-based pharmaceutical company. The Company's formulations business in India consists of 13 marketing divisions focusing on therapeutic segments, including non-steroidal anti-inflammatory drugs (NSAID), cardiovascular and anti-diabetics, anti-malarial, anti-bacterial, gastro intestinal (GI) products, cough preparations, dermatology, neuro psychiatry, urology, neutraceutical and others. The Company manufactures over 350 formulations and 80 active pharmaceutical ingredients (API). The Company also offers Disease Modifying Anti-Rheumatic Drugs treatment for rheumatoid arthritis. The Company exports its APIs to the United States, Canada, Brazil, Mexico and generic formulations to the United States, Canada and branded formulations to Panama, West Indies, Venezuela, Peru and Colombia in this sub-continent.

Company Address

IPCA Laboratories Ltd

142 AB, Kandivli Industrial Esta
Kandivli (West)
MUMBAI     400067
P: +9122.66474747
F: +9122.28686954

Company Web Links